In the past decades, many neuroimaging studies have aimed to improve the scientific
understanding of human neurodegenerative diseases using MRI and PET. This article is …

Neurodegenerative disorders such as Alzheimer disease are among today's most alarming
health problems in our aging society. The clinical assessment of neurodegenerative …

As treatment modalities for neurodegenerative diseases such as Alzheimer's disease are
becoming a reality [1, 2], it is important to be able to assess the potential patient's brains with …

Neuroimaging tools, including magnetic resonance imaging (MRI), positron emission
tomography (PET), and others (computerized tomography (CT), single-photon emission …

PET-MRI provides simultaneous of anatomical, functional, biochemical and metabolic
information for the personalized characterization and monitoring of neurological diseases. In …

There is an increasing role for biological markers (biomarkers) in the understanding and
diagnosis of neurodegenerative disorders. The application of imaging biomarkers …

The improvement of existing techniques and the development of new molecular imaging
methods are an exciting and rapidly developing field in clinical care and research of …

Neuroimaging comprises a powerful set of instruments to diagnose various disorders that
cause dementia, clarify their neurobiology, and monitor their treatment. MRI depicts volume …

Neurodegenerative disorders represent a significant and growing global health challenge,
necessitating continuous advancements in diagnostic tools for accurate and early detection …

The spectrum of neurodegenerative diseases covers the dementias, parkinsonian
syndromes, Huntington disease, amyotrophic lateral sclerosis, and prion diseases. In these …